Shattuck Labs, Inc.
STTK
Rank in Stocks
#12079
Shattuck Labs, Inc. operates as a biotechnology firm based in the United... Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission is to create innovative therapeutics designed to combat both cancer and autoimmune diseases. The company's leading experimental compound, SL-172154, is presently undergoing Phase 1 clinical assessment for the treatment of ovarian, fallopian tube, and peritoneal cancers. Furthermore, Shattuck Labs is advancing another product candidate, SL-279252, which is also in Phase 1 trials for patients afflicted with advanced solid tumors and lymphoma. Established in 2016, the company maintains its corporate headquarters in Austin, Texas.
Share Price
$4.99
Last synced: 2026-11-09
Market Cap
$500.81M
Change (1 day)
8.01%
Change (1 year)
152.02%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Shattuck Labs, Inc. (STTK)
Category
Healthcare
EPS for Shattuck Labs, Inc. (STTK)
EPS as of September 2026 TTM: $-0.51
According to Shattuck Labs, Inc.'s latest financial reports, its current EPS (TTM) is $-0.51. At the end of 2025 the company had an EPS of $-0.70, an increase over its 2024 EPS of $-1.49.
EPS history for Shattuck Labs, Inc. from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.51 | -27.14% |
| 2025 | $-0.70 | -53.02% |
| 2024 | $-1.49 | -27.32% |
| 2023 | $-2.05 | -14.94% |
| 2022 | $-2.41 | 125.23% |
| 2021 | $-1.07 | 21.59% |
| 2020 | $-0.88 | 54.39% |
| 2019 | $-0.57 | 16.33% |
| 2018 | $-0.49 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -3,170.59% |
US
|
|
| $-7.07 | 1,286.27% |
US
|
|
| $-5.29 | 937.25% |
AU
|
|
| $12.88 | -2,625.51% |
BE
|
|
| $21.56 | -4,327.45% |
NL
|
Questions about Shattuck Labs, Inc.'s earnings per share (EPS)
What is Shattuck Labs, Inc.'s earnings per share (EPS)?
Shattuck Labs, Inc.'s earnings per share (EPS) over the last twelve months is $-0.51, as of Sep 2026.
What was Shattuck Labs, Inc.'s earnings per share (EPS) in 2025?
In 2025, Shattuck Labs, Inc.'s earnings per share (EPS) was $-0.70, compared with $-1.49 in 2024.
How has Shattuck Labs, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Shattuck Labs, Inc.'s earnings per share (EPS) was highest in 2025 ($-0.70) and lowest in 2022 ($-2.41).
How does Shattuck Labs, Inc.'s earnings per share (EPS) compare with similar companies?
Shattuck Labs, Inc.'s earnings per share (EPS) ($-0.51) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.